GAAP and non-GAAP revenues of $229.7 million , up 13.4% year-over-year GAAP net income per diluted share of $0.26 , up 225.0% year-over-year Non-GAAP net income per diluted share of $0.66 , up 8.2% year-over-year Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif....
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Apr. 28, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, May 7, 2020 , to discuss the Company’s First Quarter 2020...
Record annual GAAP and non-GAAP revenues of $897.0 million Record 2019 GAAP net income per diluted share of $1.43 Record 2019 non-GAAP net income per diluted share of $2.81 Record ending product backlog of $588 million MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Feb. 6, 2020-- Omnicell, Inc....
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 30, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 6, 2020 , to discuss the Company’s Fourth Quarter...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 18, 2019-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers ,...
Company Focused on Advancing Capabilities in Automation, Intelligence and Services to Create Zero-Error, Fully Automated Medication Management Infrastructure MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 10, 2019-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Nov. 19, 2019-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced they will host an Investor and Analyst meeting at the Annual ASHP Midyear Meeting...
Record GAAP and non-GAAP revenues of $228.8 million , up 12.0% year-over-year GAAP net income per diluted share of $0.46 , up 39.4% year-over-year Record non-GAAP net income per diluted share of $0.76 , up 20.6% year-over-year MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 24, 2019-- Omnicell, Inc....
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 17, 2019-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 24, 2019 , to discuss the Company’s Third Quarter...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Aug. 27, 2019-- Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers ,...
